CClinicalTrials.gg
Not yet recruitingNCT06098703Updated Oct 25, 2023

CARD for Community Pharmacy Vaccinations

An interventional study of CARD (Comfort Ask Relax Distract) in Vaccination Reaction, Vaccination Pain and Community Pharmacy, sponsored by University of Toronto. Not yet recruiting at 1 site in Canada. Open to participants aged 0 Years and older, including healthy volunteers. Per ClinicalTrials.gov, last updated 2023-10-25.

Sponsored by University of Toronto · Not applicable, Interventional, and Treatment

From the registry’s dates

  • Primary completion was expected by Jan 2024, 2 years 8 months ago, but the record still lists the study as not yet recruiting.
Phase
Not applicable
Study type
Interventional
Enrollment
2,000
Allocation
Randomized
Ages
0 Years and older
Sex
All
01

Study summary

To integrate CARD in community pharmacy-led vaccinations and document impact on vaccine clients and pharmacy staff.

Read the detailed description

It is estimated that 1 out of 5 children and adults are not vaccinated because of concerns about pain and fear. The CARD (Comfort Ask Relax Distract) system is a new vaccine delivery system proven to reduce pain, fear and immunization stress-related responses. Improving the vaccination experiences of patients can improve attitudes about vaccination and increase vaccine acceptance.

The objective of this cluster randomized trial is to evaluate scaling of CARD across community pharmacies on patients vaccination symptoms, beliefs and attitudes and pharmacy staff beliefs and attitudes.

02

Conditions studied

  • Vaccination Reaction
  • Vaccination Pain
  • Community Pharmacy

Keywords

  • Vaccination reaction
  • Vaccination experience
03

In context

Lead sponsor

University of Toronto is the lead sponsor of 397 studies on the registry; 59 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
0 Years and older
Sexes eligible
All
Accepts healthy volunteers
Yes

Inclusion criteria

  • vaccine clients being vaccinated in community pharmacies participating in the project
  • pharmacy staff in community pharmacies participating in the project

Exclusion criteria

Exclusion Criteria:

  • unable to understand and read English
05

Study design

Phase
Not applicable
Primary purpose
Treatment
Allocation
Randomized
Intervention model
Parallel assignment
Masking
Double (Participant, Outcomes assessor)
Enrollment
2,000 participants (estimated)

Study arms

  • Experimental
    CARD (multi-faceted intervention)

    CARD will be integrated in the pharmacy vaccination process. This includes education, environment (e.g., clinic spaces), engagement (interactions), and evaluation (surveys/feedback).

    Behavioral: CARD (Comfort Ask Relax Distract)

  • No intervention
    Control (standard care)

    There are no specific procedures being undertaken to plan or execute vaccine clinics. Usual practices will be instituted by participating pharmacies.

Interventions

  • BehavioralCARD (Comfort Ask Relax Distract)

    CARD is a vaccine delivery framework/protocol to plan and deliver vaccinations

06

What researchers measure

Primary outcomes

  1. Experience with vaccination

    Vaccine client self-reported experience with vaccination (better or not)

    Time frame: within 15 minutes after vaccination

Secondary outcomes

  1. Fear

    Vaccine client self-reported fear during vaccination (0-10)

    Time frame: within 15 minutes after vaccination

  2. Pain

    Vaccine client self-reported pain during vaccination (0-10)

    Time frame: within 15 minutes after vaccination

  3. Dizziness

    Vaccine client self-reported dizziness during vaccination (0-10)

    Time frame: within 15 minutes after vaccination

  4. Fainting

    Fainting during/after vaccination (yes/no)

    Time frame: within 15 minutes after vaccination

  5. Utilization of coping strategies during vaccination

    Use of individual coping strategies during vaccination (e.g., distraction, support person) (yes/no)

    Time frame: within 5 minutes of vaccination

  6. CARD satisfaction survey

    Vaccine client self-reported satisfaction with CARD (e.g., helpfulness, willingness to use again, willingness to return for next vaccination, vaccination decision-making, as applicable), responses reported for individual items

    Time frame: within 15 minutes of vaccination

  7. Implementation success of CARD

    Perceptions of implementation success of CARD program delivery as reported by CARD implementers (primary targets) using CARD Global Impression Checklist, individual questions (5-point Likert Scale higher number represents better outcome); responses reported for individual items. This information is supplemented with focus group information and study notes.

    Time frame: within 3 months of vaccination clinics

  8. Attitudes about vaccination

    Perceptions of CARD and non-CARD implementers using CARD Attitudes survey, individual questions (5-point Likert Scale higher number represents better outcome); responses reported for individual items. This information is supplemented with focus group information and study notes.

    Time frame: within 3 months of vaccination clinics

  9. Vaccination behaviours

    Self-reported vaccine behaviours of immunizers using CARD Behaviour Survey, individual questions (rank as whether behaviours are done or not); responses reported for individual items. Includes CARD and non-CARD implementers.

    Time frame: within 3 months of vaccination clinics

  10. Vaccine interaction survey

    Perceptions of CARD and non-CARD immunizers about vaccination interaction \[duration, satisfaction, CARD usefulness (intervention group only)\]; responses reported for individual items.

    Time frame: within 5 minutes of vaccination

07

Study locations

1 site
  • Anna Taddio
    Toronto, Ontario M5S 3M2, Canada
08

References and documents

Individual participant data

Plan to share: No — We do not have permission to share this information.

No publications or documents are linked to this record.

09

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Oct 25, 2023, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT06098703
Lead sponsor
University of Toronto
Collaborators
Public Health Agency of Canada (PHAC), Wholehealth Pharmacy Partners
Responsible party
Anna Taddio (Professor, University of Toronto) — Principal investigator
First posted
Oct 24, 2023
Start date
Nov 1, 2023 (estimated)
Primary completion
Jan 31, 2024 (estimated)
Completion
Dec 31, 2024 (estimated)
Last update
Oct 25, 2023

Study contacts

Charlotte Logeman, MPH
Contact
charlotte.logeman@utoronto.ca
416-978-2889
Victoria Gudzak, MSc
Contact
victoria.gudzak@mail.utoronto.ca
416-978-2889
Anna Taddio, PhD
principal investigator · University of Toronto

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is not yet recruiting, as verified in Oct 2023. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion